Pediatric Rheumatology Online Journal (Sep 2023)

A case of neonatal sweet syndrome associated with mevalonate kinase deficiency

  • Margaret Irwin,
  • Veeraya K. Tanawattanacharoen,
  • Amy Turner,
  • Mary Beth F. Son,
  • Rebecca C. Hale,
  • Craig D. Platt,
  • Juan Putra,
  • Birgitta A.R. Schmidt,
  • Mollie G. Wasserman

DOI
https://doi.org/10.1186/s12969-023-00887-8
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Sweet syndrome (SS), also known as acute febrile neutrophilic dermatosis, is an immunologic syndrome characterized by widespread neutrophilic infiltration. Histiocytoid Sweet syndrome (H-SS) is a histopathologic variant of SS. While SS most commonly occurs in adults, this case report discusses an infant patient who presented with H-SS. Case presentation Through a multidisciplinary approach, this patient was also found to have very early onset inflammatory bowel disease (VEO-IBD) and Mevalonate kinase-associated disease (MKAD). While prior case studies have characterized an association between VEO-IBD and MKAD, there is no literature describing the association of all three diagnoses this case: H-SS, VEO-IBD and MKAD. Initiation of canakinumab in this patient resulted in successful control of the disease. Conclusions This case highlights the importance of a multidisciplinary approach to rare diagnoses, and collaboration during cases with significant diagnostic uncertainty.

Keywords